3D printed tissue is proving to be an effective means of testing new pharmaceuticals, meaning that drugs can be thoroughly assessed and brought to market more quickly, all without harming animal test subjects. A group of researchers recently published a paper discussing the development of a new type of bioink that enables the 3D printing of cells and other biological materials as part of a single production process. In the opinion of these researchers, the possibilities bioprinting offers for drug development may be the most important use of the technology. Read more at 3DPrint.com: http://3dprint.com/182475/drug-testing-3d-bioprinting/